J. Faust

Preoperative induction of CPT‐11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with locoregional carcinoma of the esophagus or gastroesophageal junction

J. Ajani, J. Roth, S. Swisher, 2004, Cancer.

Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome.

J. Ajani, Tsung-Teh Wu, B. Feig, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A multi-center phase II study of sequential paclitaxel and bryostatin-1 (NSC 339555) in patients with untreated, advanced gastric or gastroesophageal junction adenocarcinoma

J. Ajani, A. Bleyer, James C Yao, 2006, Investigational New Drugs.

Phase I pharmacokinetic study of S-1 plus cisplatin in patients with advanced gastric carcinoma.

J. Ajani, James C. Yao, K. Ikeda, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of Induction Chemotherapy and Preoperative Chemoradiotherapy on Operative Morbidity and Mortality in Patients with Locoregional Adenocarcinoma of the Stomach or Gastroesophageal Junction

J. Ajani, S. Swisher, B. Feig, 2007, Annals of Surgical Oncology.

Impact of Induction Chemotherapy and Preoperative Chemoradiotherapy on Operative Morbidity and Mortality in Patients with Locoregional Adenocarcinoma of the Stomach or Gastroesophageal Junction

J. Ajani, S. Swisher, B. Feig, 2006, Annals of Surgical Oncology.

Longterm survival of a Western patient with metastatic gastric cancer treated with S-1 plus cisplatin

J. Ajani, E. Tetzlaff, J. Faust, 2006, Gastric Cancer.

Irinotecan/cisplatin followed by 5-FU/paclitaxel/radiotherapy and surgery in esophageal cancer.

J. Ajani, J. Roth, S. Swisher, 2003, Oncology.